Sweet 16: Novel APP Processing Pathway and a New Biomarker?
Using mass spectrometry, researchers identified novel C-truncated forms of Aβ in human cerebrospinal fluid (CSF)...
6401 RESULTS
Sort By:
Using mass spectrometry, researchers identified novel C-truncated forms of Aβ in human cerebrospinal fluid (CSF)...
Toronto: Human Amyloid Imaging Conference Showcases a Maturing Field Toronto: Ah, The Devil in the Details Toronto: Last Gift to Science—Hospice Patients Validate Amyloid Ligand Toronto: Sister 18F Ligands Jostle for Primacy Toronto: HAI Amyloid Imaging C
A genetic variant near the gene for MTHFD1L on chromosome 6 likely doubles a person’s risk of late-onset Alzheimer disease...
Researchers used two-photon calcium imaging to look more directly at real-time microcircuit dynamics in awake, active mice...
Researchers in Japan have developed an assay for amyloid-β (Aβ) oligomers that they suggest might be a useful diagnostic test for Alzheimer disease...
The latest gene to join the amyotrophic lateral sclerosis canon is D-amino acid oxidase, an enzyme that protects motor neurons from excitotoxicity...
It was once <em>All About Eve</em>, but what about Adam, or ADAM10, to be more precise?...
Japanese scientists have now incorporated an unusual variant of amyloid precursor protein (APP) into a new mouse model...
Mounting scientific evidence continues to dash once-high hopes that lithium can help people with amyotrophic lateral sclerosis...
Many neurodegenerative diseases involve a common pattern of protein misfolding, aggregation, and toxicity...
An analysis provides evidence that caspase activation may precede tangle formation...
It is easy to confuse one motor neuron disease for another: amyotrophic lateral sclerosis, primary lateral sclerosis, and lower motor neuron disease can all mimic each other...
Advances in therapy saw little sprigs of news pop up in talks that otherwise took stock of the current status of immunotherapy as one of the major new approaches...
Following disappointing results in its Phase 3 CONNECTION trial of Dimebon for Alzheimer disease (AD), Medivation, Inc., is cutting its workforce...
Researchers have identified some potential drug targets; ARF’s regular readers may not be surprised that one of their strongest hits points to the immune system...
No filters selected